CSG, Shares

CSG Shares Sink to Within 5% of Low Despite €17B Backlog and New Defence Contracts

20.06.2026 - 18:33:21 | boerse-global.de

Prague-listed defense group's shares plunge 25% in a month, trading near annual low of €13.65, even as it unveils Trident air defense system and reports strong Q1 growth. Investors await H1 results.

CSG Stock Near 52-Week Low Despite €17B Order Book and New Defense Deals
CSG - CSG Shares Sink to Within 5% of Low Despite €17B Backlog and New Defence Contracts 20.06.2026 - Bild: über boerse-global.de

Investors are treating CSG’s record order book and heavy Eurosatory presence as irrelevant, sending the stock to within a whisker of its 52-week low even as the company touts a €17 billion pipeline and a new air defence system. The Prague-listed defence group closed at €14.28 on Friday, a mere 4.6% above the annual trough of €13.65 hit on May 4. Over the past month the shares have plunged nearly 25%, while the weekly showing was a modest 1.25% decline.

The technical picture offers little comfort. The 14-day relative strength index sits at 35.3, hovering just above the oversold threshold of 30 but still signalling persistent weakness. The stock now trades 19% below its 50-day moving average of €17.56 and a staggering 60% below the 100-day average of €23.25. From the January peak of €36.05, the decline has erased more than 60% of the company’s market value. Annualised 30-day volatility of 55.75% underscores the nervous trading that has gripped the name.

Yet CSG’s operational snapshot remains robust. In the first quarter of 2026, revenue rose 13.8% year-on-year to €1.544 billion, while operating EBIT climbed 8.7% to €372 million — a margin of roughly 24%. The order backlog expanded from €15 billion to €17 billion, and the pipeline of projects under negotiation stands at €27 billion. For the full year, management targets revenue between €7.4 billion and €7.6 billion with an EBIT margin of 24% to 25%. Large-calibre ammunition output is expected to jump from 550,000 rounds to around 850,000 as scale-up efforts continue.

Should investors sell immediately? Or is it worth buying CSG?

None of these tailwinds were enough to lift the stock during last week’s Eurosatory defence fair in Paris, where CSG staged one of the largest exhibitions from a Czech defence company. Two announcements dominated the show. First, the group unveiled the Trident modular air defence platform, capable of engaging targets at short, medium and long ranges using guided missiles, guns, counter-drone systems and electronic warfare. Excalibur International serves as system architect, Retia supplies radar and command systems, Tatra Trucks and Tatra Defence provide vehicle platforms, and Turkish contractor Roketsan was named strategic partner for surface-to-air missiles.

Second, CSG subsidiary AviaNera Technologies inked a partnership with Ukrainian Armor LLC on June 15 covering propulsion solutions for Ukrainian missile and drone systems, with plans for joint ventures and local technology transfer. Despite the weight of these deals, the shares barely budged — the daily move on Friday was a fraction of a percent.

The market’s indifference reflects a growing impatience with announcements that do not immediately improve near-term earnings visibility. Backlog conversion and production ramp-ups take time, and investors are demanding proof that the massive order pipeline will translate into steadily rising margins and cash flows. Until CSG delivers hard evidence — perhaps in the first-half results due on August 7 — the stock may remain under pressure. The €13.65 support level is the next key line in the sand; a break below it could accelerate the selling, while a hold would likely redirect attention back to the company’s operational heft.

Ad

CSG Stock: New Analysis - 20 June

Fresh CSG information released. What's the impact for investors? Our latest independent report examines recent figures and market trends.

Read our updated CSG analysis...

en | NL0015073TS8 | CSG | boerse | 69591883 |